Silencing DRP1 or overexpressing Mfn1 led to mitochondrial elongation or clustering, respectively, significantly inhibiting the metastatic ability of breast cancer cells (Zhao et al. 2013). This evidence concerns the gene MFN1 and breast carcinoma.